These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 20822351)

  • 1. Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses.
    Oyewumi MO; Kumar A; Cui Z
    Expert Rev Vaccines; 2010 Sep; 9(9):1095-107. PubMed ID: 20822351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of size on particulate vaccine adjuvants.
    Shah RR; O'Hagan DT; Amiji MM; Brito LA
    Nanomedicine (Lond); 2014 Dec; 9(17):2671-81. PubMed ID: 25529570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of nanoparticle adjuvants to potentiate the immune response against diphtheria toxoid.
    Alshanqiti FM; Al-Masaudi SB; Al-Hejin AM; El-Baky NA; Redwan EM
    Hum Antibodies; 2018 Feb; 26(2):75-85. PubMed ID: 29171990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination with nanoparticles combined with micro-adjuvants protects against cancer.
    Mohsen MO; Heath MD; Cabral-Miranda G; Lipp C; Zeltins A; Sande M; Stein JV; Riether C; Roesti E; Zha L; Engeroff P; El-Turabi A; Kundig TM; Vogel M; Skinner MA; Speiser DE; Knuth A; Kramer MF; Bachmann MF
    J Immunother Cancer; 2019 Apr; 7(1):114. PubMed ID: 31027511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine adjuvants: putting innate immunity to work.
    Coffman RL; Sher A; Seder RA
    Immunity; 2010 Oct; 33(4):492-503. PubMed ID: 21029960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unmet needs in modern vaccinology: adjuvants to improve the immune response.
    Leroux-Roels G
    Vaccine; 2010 Aug; 28 Suppl 3():C25-36. PubMed ID: 20713254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies to link innate and adaptive immunity when designing vaccine adjuvants.
    Garlapati S; Facci M; Polewicz M; Strom S; Babiuk LA; Mutwiri G; Hancock RE; Elliott MR; Gerdts V
    Vet Immunol Immunopathol; 2009 Mar; 128(1-3):184-91. PubMed ID: 19042032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plant Phenolics and Lectins as Vaccine Adjuvants.
    Reyna-Margarita HR; Irais CM; Mario-Alberto RG; Agustina RM; Luis-Benjamín SG; David PE
    Curr Pharm Biotechnol; 2019; 20(15):1236-1243. PubMed ID: 31333121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modes of Action for Mucosal Vaccine Adjuvants.
    Aoshi T
    Viral Immunol; 2017; 30(6):463-470. PubMed ID: 28436755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aluminium Nanoparticles as Efficient Adjuvants Compared to Their Microparticle Counterparts: Current Progress and Perspectives.
    Nazarizadeh A; Staudacher AH; Wittwer NL; Turnbull T; Brown MP; Kempson I
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological Mechanism and Clinical Application of PAMP Adjuvants.
    Yan Y; Yao D; Li X
    Recent Pat Anticancer Drug Discov; 2021; 16(1):30-43. PubMed ID: 33563182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond adjuvants: Antagonizing inflammation to enhance vaccine immunity.
    Alter G; Sekaly RP
    Vaccine; 2015 Jun; 33 Suppl 2():B55-9. PubMed ID: 26022570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polysaccharides as vaccine adjuvants.
    Sun B; Yu S; Zhao D; Guo S; Wang X; Zhao K
    Vaccine; 2018 Aug; 36(35):5226-5234. PubMed ID: 30057282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel adjuvants and delivery systems for enhancing immune responses induced by immunogens.
    Dey AK; Srivastava IK
    Expert Rev Vaccines; 2011 Feb; 10(2):227-51. PubMed ID: 21105782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity.
    Marciani DJ
    Drug Discov Today; 2003 Oct; 8(20):934-43. PubMed ID: 14554157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microparticles as vaccine adjuvants and delivery systems.
    O'Hagan DT; Singh M
    Expert Rev Vaccines; 2003 Apr; 2(2):269-83. PubMed ID: 12899577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent developments in vaccine delivery systems.
    O'Hagan DT
    Curr Drug Targets Infect Disord; 2001 Nov; 1(3):273-86. PubMed ID: 12455401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Starch microparticles as vaccine adjuvant.
    Rydell N; Stertman L; Sjöholm I
    Expert Opin Drug Deliv; 2005 Sep; 2(5):807-28. PubMed ID: 16296780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticles as adjuvants for vaccines.
    Kreuter J
    Pharm Biotechnol; 1995; 6():463-72. PubMed ID: 7551231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Particulate adjuvant and innate immunity: past achievements, present findings, and future prospects.
    Kuroda E; Coban C; Ishii KJ
    Int Rev Immunol; 2013 Apr; 32(2):209-20. PubMed ID: 23570316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.